Vilco Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-07-2024
- Paid Up Capital ₹ 5.00 M
as on 03-07-2024
- Company Age 43 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 43.90 M
as on 03-07-2024
- Revenue 3.20%
(FY 2022)
- Profit -44.14%
(FY 2022)
- Ebitda -48.25%
(FY 2022)
- Net Worth 3.68%
(FY 2022)
- Total Assets 3.86%
(FY 2022)
About Vilco Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹4.39 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Husein Vakil and Mumtaz Vakil serve as directors at the Company.
- CIN/LLPIN
U85195MH1981PTC024773
- Company No.
024773
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 1981
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vilco Laboratories Pvt Ltd offer?
Vilco Laboratories Pvt Ltd offers a wide range of products and services, including Sexual Wellness, Sexual Health Supplements, Men Performance Enhancers, Health Conditions, Cold & Cough, Pain Relief.
Who are the key members and board of directors at Vilco Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Husein Vakil  | Director | 09-Jul-1981 | Current |
| Mumtaz Vakil | Director | 02-Apr-2022 | Current |
Financial Performance and Corporate Structure Insights of Vilco Laboratories.
Vilco Laboratories Pvt Ltd, for the financial year ended 2022, experienced modest growth in revenue, with a 3.2% increase. The company also saw a substantial fall in profitability, with a 44.14% decrease in profit. The company's net worth moved up by a moderate rise of 3.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vilco Laboratories?
In 2022, Vilco Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Saurashtra Creation Date: 23 Dec 1998 | ₹1.70 Cr | Satisfied |
State Bank Of Saurashtra Creation Date: 24 Apr 1997 | ₹0.25 M | Satisfied |
State Bank Of Saurashtra Creation Date: 02 Feb 1994 | ₹0.27 M | Satisfied |
How Many Employees Work at Vilco Laboratories?
Unlock and access historical data on people associated with Vilco Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vilco Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vilco Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
